Macrophage phenotypic subtypes diametrically regulate epithelial-mesenchymal plasticity in breast cancer cells

被引:0
作者
Min Yang
Bo Ma
Hanshuang Shao
Amanda M. Clark
Alan Wells
机构
[1] University of Pittsburgh,Department of Pathology
[2] and Pittsburgh VA Health System,Current address: Institute of Materia Medica
[3] Chinese Academy Medical of Sciences & Peking Union Medical College,undefined
来源
BMC Cancer | / 16卷
关键词
Macrophage polarity; Mesenchymal to epithelial reverting transition; Epithelial to mesenchymal transition; Metastatic microenvironment;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 226 条
[11]  
Muto Y(2011)Down-regulation of epithelial cadherin is required to initiate metastatic outgrowth of breast cancer Mol Biol Cell 22 2423-560
[12]  
Tashiro H(2014)Hepatic nonparenchymal cells drive metastatic breast cancer outgrowth and partial epithelial to mesenchymal transition Breast Cancer Res Treat 144 551-10361
[13]  
Klein CA(2001)Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment Proc Natl Acad Sci U S A 98 10356-11278
[14]  
Naumov GN(2006)Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: role of fibroblast growth factor receptor-2 Cancer Res 66 11271-655
[15]  
MacDonald IC(2008)Phenotypic plasticity of neoplastic ovarian epithelium: unique cadherin profiles in tumor progression Clin Exp Metastasis 25 643-3816
[16]  
Weinmeister PM(2013)The dormancy dilemma: quiescence versus balanced proliferation Cancer Res 73 3811-2350
[17]  
Kerkvliet N(2014)Spontaneous dormancy of metastatic breast cancer cells in an all human liver microphysiologic system Br J Cancer 111 2342-265
[18]  
Nadkarni KV(2002)The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies J Pathol 196 254-163
[19]  
Wilson SM(2012)Tumour-infiltrating macrophages and clinical outcome in breast cancer J Clin Pathol 65 159-896
[20]  
Morris VL(2010)Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm Nat Immunol 11 889-51